Article
Anti-CD11b antibody prevents immunopathologic changes in viable moth-eaten bone marrow chimeric mice.
Journal of immunology (Baltimore, Md. : 1950) - 15 Dec 1993
Koo G C, Rosen H, Sirotina A, Ma X D, Shultz L D
Abstract excerpt
The effect of in vivo treatment with anti-CD11b (MAC-1) antibody (Ab) was examined in an inflammatory disease model, the viable moth-eaten (mev) mutant mouse. The autosomal recessive mev gene occurred spontaneously as a point mutation of the hematopoietic cell protein tyrosine phosphatase in C57BL/6 mice. Homozygotes (mev/mev) develop a chronic myelomonocytic inflammation, involving accumulation of myelomonocytic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
